N-(4-Iodophenyl)cyclopropanecarboxamide, 95%, 250mg

N,N-Dimethyl-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzenesulfonamide, 95.0%, 1g

tBuXPhos Pd G1, 10g

3-(4-BROMO-3-FLUOROPHENOXY)PROPANE-1,2-DIOL, 95.0%, 5g

1,3-Bis[1-(2-hydroxyethyl)-4-piperidyl]propane>98.0%(GC)25g

tert-Butyl (3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2-yl)carbamate, 97%, 250mg

2-((8S,9R,10S,11S,13S,14S,17R)-9-FLUORO-11,17-DIHYDROXY-10,13-DIMETHYL-3-OXO-6,7,8,9,10,11,12,13,14,15,16,17-DODECAHYDRO-3H-CYCLOPENTA[A]PHENANTHREN-17-YL)-2-OXOETHYL ACETATE, 95%, 250mg

1-Bromo-5-chloro-4-methoxy-2-methylbenzene, 95.0%, 250mg

H-DL-Lys-OH, 95.0%, 100g

2-Amino-N,N-diethylbenzamide, 97.0%, 1g

5-Bromo-6-chloro-2-(methylthio)pyrimidin-4-amine, 95.0%, 5g

Trimethyl((4-nitrophenyl)ethynyl)silane, 95+%, 25g

tert-Butyl (2-hydroxypropyl)(methyl)carbamate, 97%, 10g